S. Traore

Evolving quality standards for large-scale registries: the GARFIELD-AF experience

B. Gersh, A. Camm, K. Fox, 2016, European heart journal. Quality of care & clinical outcomes.

Predictive Factors of Oxaliplatin Neurotoxicity: The Involvement of the Oxalate Outcome Pathway

E. Gamelin, M. Boisdron-Celle, A. Morel, 2007, Clinical Cancer Research.

PANERB study: Panitumumab after cetuximab-based regimen failure.

J. Douillard, J. Raoul, J. Metges, 2010 .

DPD deficiency: Medicoeconomic evaluation of pretreatment screening of 5-FU toxicity.

G. Hunault, E. Gamelin, M. Boisdron-Celle, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of COVID-19 Infection in a Context of Countries with Limited Resources: Case of the University Hospital Center of Renaissance (UHCR) in N’Djamena, Chad

A. Moussa, S. Traore, Joseph Mad-Toingue, 2022, International Journal of Pathogen Research.

Overall mortality after radical nephrectomy in patients aged over 80 years with renal cancer: A retrospective study on preoperative prognostic factors

J. Patard, J. Bernhard, P. Bigot, 2012, International journal of urology : official journal of the Japanese Urological Association.

APPORT DE L'ECHOGRAPHIE DANS LE DIAGNOSTIC DE LA RUPTURE UTERINE A PROPOS DE DEUX CAS THE ROLE OF ULTRASOUND IN THE DIAGNOSIS OF UTERINE RUPTURE: A SERIES OF TWO CASES

M. Guindo, S. Traore, M. Diallo, 2013 .

Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US

J. Feliciano, D. Vanness, F. Ejzykowicz, 2019, Current medical research and opinion.

Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US

J. Feliciano, D. Vanness, T. Burke, 2018, Journal of medical economics.

Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis.

H. Thom, S. Traore, K. Haeussler, 2022, Future oncology.